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Abstract  
OBJECTIVE: To compare the therapeutic effects of the application of doxycycline-full dose (100 
mg) and sub-dose (20 mg) in the treatment of periodontal disease. 
MATERIAL AND METHODS: A total of 60 patients with periodontal disease were examined. 
Patients are divided into two groups: A) treated with antimicrobial dose of 100 mg doxycycline once 
daily for 30 days, and B) treated with 2 x 20 mg/day. doxycycline, during 75 days. Among all 
patients a conservative treatment was carried out and ordinated the proper dose doxycycline in 
total dose during treatment from 3 gr. Index of dental plaque by Löe-Sillness, index of gingival 
inflammation and gingival bleeding by Cowell were followed.  
RESULTS: Values of dental plaque in relation first examination, 10th, 20th day, 1 month and 2.5 
months, showed that after 2.5 months, average value (x = 0.83) of dental plaque in second group is 
slightly less than the value (x = 0.93) of dental plaque in the first group. The average value (x = 
0.17) of gingival inflammation in second group is significantly less than the value (x = 0.50) of 
gingival inflammation in the first group. The average value (x = 0.97) of gingival bleeding in patients 
from the first group was significantly higher than value(x = 0.37) of gingival bleeding in the second 
group. 
CONCLUSION: Patients whose therapy was helped by a sub-dose doxycycline demonstrated 
positive therapeutic effects on gingival inflammation and bleeding.  
 
 
 
 
 
 
Introduction 
 
Treatment of periodontal disease includes 
removing of dental plaque and other irritating factors 
(conservative treatment) or performing surgical 
methods, which sometimes include the use of 
antibiotic therapy administered systemically or locally 
[1, 2]. The administration of local and systemic 
antibiotics, anti-inflammatory drugs, or sub-
antimicrobial small doses of doxycycline applied as 
adjuvants have the opportunity to provide additional 
positive therapeutic effects [3, 4].
 
Sub-antimicrobial 
dose of doxycycline is 20 mg dose of the antibiotic 
applied twice daily in the treatment of periodontal 
disease. It is believed that a dose of 20 mg provides 
quite effective inhibition of enzymes, cytokines and 
osteoclasts than any antibiotic that would be applied 
in full or normal dose. On the other hand research 
studies have not spotted noticeable changes in the 
oral flora or bacterial flora in other organs in the 
individual’s body because of which they identified as 
extremely recommended dosage which is a serious 
clinical utility when applied only in addition to 
periodontal pockets debridement [3].
 
For the clinician, 
this is particularly favorable moment, which enables 
broad applicability.  
Well known fact is that periodontal disease is 
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a disease known as infection of the periodontal tissue 
complex. The primary initiation belongs to the bacteria 
which alter local immune response and result in 
appropriate tissue destruction. Due to the infectious 
nature of the disease the main aim of treatment 
should be suppression of the effective bacterial 
populations responsible for the dissolution of the 
periodontal tissues [5, 6]. Recent findings show that 
the local causal therapy conducted in the affected 
periodontium is not always sufficient to eliminate 
bacteria, so under certain conditions in the overall 
therapeutic treatment, systemic treatment with 
antibiotics may be included [6-8]. 
Bacterial plaque is a major factor for the 
initiation of chronic periodontitis (CP), but 
characteristic clinical signs (periodontal pocket depth, 
epithelial apical migration and alveolar bone 
destruction) primarily are a result of disrupted and 
insufficient immune and defense mechanisms of the 
host [9]. The success of the results varies between 
individuals and depends on the production and the 
level of proinflammatory mediators, enzymes and 
cytokines in all development stages of the disease 
[10]. 
The key between those two extremes are 
matrix metalloproteinasis (MMPs), a family of 
proteolytic enzymes released by macrophages, tissue 
fibroblasts, epithelial cells and neutrophils (PMNs). 
Damage of the collagen, the major structural protein in 
periodontium has his part in the destruction of the 
epithelial attachment and bone resorption [10]. LDH 
which helps the destructive and resorptive processes 
in periodontal tissue complex joins on these 
pathogenetic mechanisms of chronic periodontitis. 
Considering these facts we have set the goal 
of this paper: to compare the therapeutic effects of the 
application of doxycycline - from the full dose (100 
mg) and sub-dose (20 mg) in the treatment of 
periodontal disease.  
 
 
Material and Methods  
 
The choice of patients that are part of the 
study is made by chance, and is based on a personal 
position on each of them. Of those who voluntarily 
showed a wish to be part of the study, is provided 
written consent for joining in the investigation. In the 
selection of patients are taken into consideration the 
criteria for inclusion and exclusion of the study, 
according to the protocol approved by the Ethic 
Commission of Faculty of Dentistry at UKIM in Skopje. 
The study was performed of 60 patients in 
age from 30-70 years with clinically manifested mild 
form of chronic periodontitis where depth of 
periodontal pockets on certain representative group of 
teeth was estimated at 3-5 mm. The diagnosis of each 
individual of the study group was set according 
collected anamnestic data which also includes dental 
and medical history of the patients, clinical 
examinations and analysis the X-ray image. 
The selection of patients is made at the Clinic 
of oral pathology and periodonthology, at the 
University of Dental Clinical Centre in Skopje. As 
additional criterias are taken into account were the 
criteria for inclusion and exclusion of the study: 
Criteria for inclusion: patients with periodontal 
disease which manifest the periodontal pockets depth 
of 3-5 mm; patients who in the last two months are not 
receiving drugs from any group of antibiotics; patients 
with at least three teeth in one side of the jaw; and 
patients who have at least 12 teeth in the mouth. 
Criteria for exclusion: patients receiving 
systemic antimicrobial drugs; patients receiving non-
steroidal anti-inflammatory drugs; patients with 
diagnosed any cardiac, renal or acute infectious 
illness; patients in whom not conducted curettage in 
periodontal pockets in the last 3 months; smokers, 
alcoholics, pregnant women, patients with brest 
cancers; patients allergic to antibiotics; patients with 
poor oral hygiene; patients who are using any herbal 
drugs and extracts. 
Patients are divided into two groups (total n = 
60). Group A is treated with antimicrobial dose of 100 
mg doxycicline capsule (30 patients) once daily in 
progress in 30 days, and in group B with the same 
number of subjects where the ordinated dose were 2 x 
20 mg doxycicline capsule daily for 75 days. 
In all subjects, after the diagnostics and 
determining the condition, there were conducted 
conservative treatments which mean removal of 
dental calculus, soft deposites, and dental plaque and 
other iritative factors, scaling and root planing. After 
that, there was administrated doxycycline in the 
appropriate dose (depending on the group to which it 
is intended). 
The total dose that the patients received in 
the course of therapeutic treatment without distinction 
of dosage and dynamics of applications was 3 grams. 
The first group has the systemic administration of 
doxycycline 100 mg. once daily, and total planned 
dose received within 30 days. The second group of 
patients who received doxycycline twice by 20 mg 
daily (in the morning and evening) ended this therapy 
after 75 days, also in total dose of 3 g. 
Patients were conducted on following clinical 
research: Index of dental plaque, according to Löe-
Sillness; Index on gingival inflammation and gingival 
bleeding according Cowell. 
The index of dental plaque, according to Löe-
Sillness was registered with visual method through 
coloring with methylene blue, according to which was 
the numbered index which belongs to. 
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The index of gingival inflammation and 
gingival bleeding index according Cowell were 
measured separately. 
The inflammation was determined with 
inspection, and for gingival bleeding was applied the 
method of sonding, too. 
The statistical data processing was performed 
in a statistical program STATISTICA 7.1. The 
differences in the values of the dental plaque, gingival 
inflammation, gingival bleeding, periodontal pockets 
depth, clinical attachment level, overview on 10
th
 day, 
20
th
 day, 1 month and after 75 days, were tested with 
Friedman ANOVA test (ANOVA Chi Sqr.) 
The differences in the values of the dental 
plaque, gingival inflammation and gingival bleeding 
between the two subgroups of patients (patients who 
received doxycicline 2 x 20 mg daily 2.5 months and 
patients who received doxycicline 100 mg daily for 30 
days) were tested by Mann-Whitney U test (Z). 
 
 
Results 
 
Differences in values of dental plaque in the 
relation: first examination, 10
th
 day, 20
th
 day, 1 month 
and 2.5 months, as a result of the applied therapy in 
both groups are shown on Table 1. At the first 
examination for Z = 0.00 and p < 0.05 (p = 0.99) there 
was no significant difference in the average value of 
the dental plaque in both groups. 
After 10 days from the applied therapy the 
average value of dental plaque (x = 0.97) in patients 
from the second group (doxycycline 2 x 20 mg/2.5 
months) for Z = -3.15 and p < 0.01 (p = 0.002) was 
significantly higher than the average value of the in 
dental plaque (x = 0.37) in patients from the first group 
(doxycycline100 mg/30 days). 
After 20 days from the applied therapy the 
average value (x = 0.43) on dental plaque in patients 
from the second group (doxycycline 2 x 20 mg/2.5 
months) for Z = 0.22 and p> 0.05 (p = 0.82) is only 
slightly lower than the average value (x = 0.47) of 
dental plaque in patients from the first group (100 mg 
doxycycline/30 days). 
After 1 month of the applied therapy the 
average value (x = 0.33) of dental plaque in patients 
from the second group (doxycycline 2 x 20 mg/2.5 
months) for Z = -0.44 and p > 0.05 (p = 0.66) was only 
slightly higher than the average value of the (x = 0.27) 
in dental plaque in patients from the first group 
(doxycycline100 mg/30 days). 
After 2.5 months, the average value (x = 0.83) 
of dental plaque in patients of the second group 
(doxycycline 2 x 20 mg/2.5 months) for Z = 0.63 and p 
< 0.05 (p = 0.53) unsignificantly is less than the 
average value (x = 0.93) of dental plaque in patients 
from the group A (doxycycline 100 mg/30 days) (Table 
1). 
Table 1: The difference between the investigated groups 
according to the received value of dental plaque in all 
investigated time intervals 
Dental  
plaque  
Rank Sum 
1 x 100 mg 
Rank Sum 
2 x 20 mg 
U Z p-level Valid N 
1 x 100 mg 
Valid N 
2 x 20 mg 
First examin  914.00 915.00 450.00 0.00 0.99 30 30 
10th day  702.00 1128.00 237.00 -3.15 0.002 30 30 
20 th day  930.00 900.00 435.00 0.22 0.82 30 30 
1 month  885.00 945.00 420.00 -0.44 0.66 30 30 
2.5 months  957.50 872.50 407.50 0.63 0.53 30 30 
 
Mean differences between index of gingival 
inflammation in relation with first check up, 10
th
 day, 
20
th
 day, one month and 2.5 month later, as a result of 
applied therapy in both examined groups, are shown 
in Table 2.  
On the first check up mean value (x = 1.57) of 
gingival inflammation was slightly greater than the 
average value in patient from second group x = 1.47), 
Z = 0.41 and p > 0.05 (p = 0.68). 
Ten days after applied therapy average 
values of gingival inflammation in patient from the first 
group (x = 0.83) was significantly greater than the 
average values in second group (x = 0.40), Z = 2.62 
and p < 0.01 (p = 0.009). 
Twenty days after applied therapy there are 
not significantly differences in the average values of 
index of gingival inflammation between examined 
groups, Z = 0.00 and p > 0.05 (p = 0.99). 
One month after applied therapy there are not 
significantly differences in the average values of index 
of gingival inflammation between examined groups, Z 
= 0.00 and p > 0.05 (p = 0.99).  
On the check up two and a half months after 
applied therapy average values conducted in patients 
from second group were significantly smaller than the 
consequently values in patient from the first group, Z = 
2.22 and p > 0.05 (p = 0.03) (Table 2). 
Table 2: Difference between examined groups according to the 
obtained values of index of gingival inflamation between all 
tested intervals 
Gingival  
inflamation  
Rank Sum 
100 mg 
Rank Sum 
2 x 20 mg 
U Z p-level Valid N 
100 mg 
Valid N 
2  x 20 mg 
First examin  942.50 887.50 422.50 0.41 0.68 30 30 
10th day  1092.00 738.00 273.00 2.62 0.009 30 30 
20th day  915.00 914.00 450.00 0.00 0.99 30 30 
1 month  914.00 915.00 450.00 0.00 0.99 30 30 
2.5 months  1065.00 765.00 300.00 2.22 0.06 30 30 
 
Mean differences between index of bleeding 
of probing BOP in relation with first check up, 10
th
 day, 
20
th
 day, one month and 2.5 month later, as a result of 
applied therapy in both examined groups, are shown 
in Table 3.  
On the first check up there are not any 
significant differences between two examined groups, 
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Z = 0.00 and p > 0.05 (p = 0.99). 
Then days after applied therapy average 
values on BOP index was slightly greater in patients 
which consisted second group, but without 
significantly differences between both examined 
groups, Z = 1.12 and p > 0.05 (p = 0.26). 
Twenty days and one month after applied 
therapy there are not any significant differences 
between two examined groups, Z = 0.00 and p > 0.05 
(p = 0.99). 
On the check up two and a half months after 
applied therapy average values conducted in patients 
from second group were significantly smaller than the 
consequently values in patient from the first group, Z = 
-3.49 and p < 0.001 (p = 0.000) (Table 3). 
Table 3: Difference between examined groups according to the 
obtained values of BOP in all tested intervals 
Gingival  
bleeding  
Rank Sum 
2 x 20 mg 
Rank Sum 
1 x 100 mg 
U Z p-level Valid N 
100 mg 
Valid N 
2 x 20 mg 
First examin  914.00 915.00 450.00 0.00 0.99 30 30 
10th day  991.00 839.00 374.00 1.12 0.26 30 30 
20th day  915.00 914.00 450.00 0.00 0.99 30 30 
1 month  914.00 915.00 450.00 0.00 0.99 30 30 
2.5 months  679.00 1151.00 214.00 -3.49 0.000 30 30 
 
 
Discussion 
 
Today there are a lot of antibiotics which may 
be ordained, locally or systemically [11].
 
Tetracyclines 
are one of the antibiotics that have a broad spectrum 
of activity and are able to inhibit the anaerobic 
microorganisms. The literature shows that it is 
possible to happen in a very short period, usually 5 
days [12]. It has been proven that doxycycline is the 
most common antibiotic that belongs to the group of 
antimicrobials that are active against most 
periopatogens due to low minimum inhibitory 
concentration (MIC) [13]. 
In our study are compared clinical effects in 
patients with chronic periodontitis treated with 
doxycycline 100 mg. once a day for one month and 20 
mg doxycycline twice daily in period of 2.5 months. 
It is evident from the study, that despite the 
first clinical examination in patients from both groups, 
all index values recorded improved clinical findings 
whether it is a dose of 100 mg or 40 mg daily. 
  Descriptive statistics of index of dental plaque 
according to Löe-Sillness at patients undergoing 
systemic application of doxycycline 100 mg once daily 
for 30 days, showed variation and systematic 
reduction from the first examination to period of 75 
days. The differences between the values of dental 
plaque in relation to first examination, 10th, 20th day, 
1 month and 2.5 months for ANOVA Chi Sqr. = 81.00 
and p < 0.001 (p = 0.000) there is significant 
difference between the values of dental plaque in 
analyzed relation. We get almost identical findings 
with gingival inflammation and gingival bleeding. 
The average value of gingival bleeding (x = 0.93) after 
2.5 months Z = 3.30 and p <0.001 (n = 0.000) is 
significantly lower than the average value of gingival 
bleeding (x = 1.53) at the first examination. 
From the obtained findings it is quite certain 
that improved clinical effects were obtained after 
applying doxycycline in dose 2 x 20 mg. 
Differences in values of dental plaque in relation first 
examination, 10th, 20th day, 1 month and 2.5 months, 
as a result of the applied therapy in both groups 
shows that after 2.5 months average value of dental 
plaque (x = 0.83) in patients in the second group (2 x 
20 mg doxycycline/2.5 months) for Z = 0.63 and p > 
0.05 (p = 0.53) is slightly lower than the average value 
(x = 0.93) of dental plaque of patients in the first group 
(doxycycline 100 mg/30 days). Evaluation of all 
remaining clinical parameters showed definite 
advantages in the group treated with sub-dose 2 x 20 
mg doxycycline. After 2.5 months average value (x = 
0.17) of gingival inflammation in patients in the second 
group (2 x 20 mg.doxycycline/2.5 months) for Z = 2.22 
and p > 0.05 (p = 0.03) was significantly lower than 
the average value (x = 0.50) of gingival inflammation 
in patients from the first group (doxycycline 100 mg/30 
days). 
In terms of index of gingival bleeding, after 2.5 
months, average value of gingival bleeding (x = 0.97) 
at patients in the first group (doxycycline 1 x 100 mg 
daily/2.5 months) and Z = -3.49, p < 0.001 (n = 0.000) 
was significantly greater than the average value of 
gingival bleeding (x = 0.37) at patients in the second 
group (doxycycline 2 x 20 mg/30 days). 
The rationale for choosing the application of 
doxycycline in addition to conventionally applied 
method is supported by its ability to achieve higher 
concentrations in gingival cervical fluid, and the 
possibility of modulating the clinical effect on the host. 
Doxycycline inhibits matrix metalloproteinase’s, which 
mediates in reduced opportunities for periodontal 
breakdown, which first manifests itself in reduced 
gingival inflammation and reduced gingival bleeding 
[14]. Some studies have failed to find a positive 
therapeutic effect of doxycycline doxycycline [15-17]. 
Although in the literature exists quite 
conflicting results, tetracycline and its related drugs 
are known to participate in the activation of latent pro-
MMP, MMP de-escalation, and neutralizing oxidative 
mechanisms responsible for periodontal tissue 
destruction ]18, 19]. This evidence provided the basis 
for a new therapeutic approach to control periodontal 
disease not only in healthy people, but also in those 
with compromised medical health, especially among 
patients with diabetes mellitus for the use of 
tetracycline and their derivatives in the treatment of 
periodontal disease [20[. Our findings are consistent 
with the findings of many authors [4, 21-25]. 
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In this regard, we support the notion that 
systemic antibiotics administered as adjunctive 
therapy in sub- antimicrobial dose, may offer an 
additional advantage over the conducted conventional 
therapy. In this context primarily refers to the clinical 
loss of attachment and periodontal pocket depth. 
However, differences in study methodology and lack 
of certain facts can be a serious handicap for 
comprehensive analysis. It was difficult to extract 
definitive conclusions from the study, although 
patients with deep pockets, progressive or "active 
form" of the disease or specific microbial profile, can 
be beneficial after this additional treatment [26]. In 
contrast to these findings [27] concluded that the 
evidence for the additional benefit of adjuvant therapy 
with antibiotics in patients with chronic periodontitis is 
insufficient and unconvincing. Based on the obtained 
findings of the survey we can conclude that in patients 
whose therapy was supported by a sub-dose 
doxycycline 2 x 20 mg demonstrated positive clinical 
therapeutic effects on gingival inflammation and 
gingival bleeding. 
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